Literature DB >> 19148557

The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity.

Masayoshi Yamaguchi1, M Neale Weitzmann.   

Abstract

Estrogen (17beta-estradiol) and genistein, a phytoestrogen, are both endowed with anabolic activities on bone in vivo and stimulate osteoblastic differentiation and mineralization in vitro. However, the mechanisms by which these agents promote osteoblastic differentiation and bone anabolic responses are multifactorial and only partly understood. Recently, the NF-kappaB signal transduction pathway was implicated as a negative regulator of osteoblastic differentiation and suppression of this pathway leads to osteoblastic differentiation and mineralization in vitro. To examine whether estrogen and/or genistein regulate osteoblast differentiation by modulating the NF-kappaB pathway, we examined the effect of 17beta-estradiol and genistein on basal and TNFalpha-stimulated NF-kappaB activity in the preosteoblastic cell line MC3T3. MC3T3 cells were transiently transfected with an NF-kappaB responsive luciferase reporter and cultured for 24 h with either vehicle, or physiological doses of 17beta-estradiol (10(-9) to 10(-7) M), or genistein (10(-6) to 10(-5) M). Our data reveal that while 17beta-estradiol had no effect on basal NF-kappaB activity in MC3T3 cells, it significantly antagonized NF-kappaB activity induced by TNFalpha (1 or 10 ng/ml). By contrast, genistein (10(-6) or 10(-5) M) significantly increased NF-kappaB activity, and showed no antagonistic effects on TNFalpha-induced NF-kappaB promoter activity. These studies suggest that the estrogenic compounds, 17beta-estradiol and genistein, mediate very different actions on osteoblastic cells. While 17beta-estradiol may stimulate bone anabolism, in part, by antagonizing TNFalpha-induced NF-kappaB activation, genistein not only fails to prevent cytokine-induced NF-kappaB activation, but directly promotes NF-kappaB activation in MC3T3 cells. These data suggest important mechanistic differences in the mechanisms by which 17beta-estradiol and genistein promote osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148557

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  16 in total

1.  Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.

Authors:  Masayoshi Yamaguchi; M Neale Weitzmann
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

Review 2.  Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2012-04-05       Impact factor: 3.396

Review 3.  Functions of nuclear factor kappaB in bone.

Authors:  Brendan F Boyce; Zhenqiang Yao; Lianping Xing
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

4.  Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo.

Authors:  George R Beck; Shin-Woo Ha; Corinne E Camalier; Masayoshi Yamaguchi; Yan Li; Jin-Kyu Lee; M Neale Weitzmann
Journal:  Nanomedicine       Date:  2011-11-16       Impact factor: 5.307

5.  Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro.

Authors:  Masayoshi Yamaguchi; Robert M Levy
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

6.  TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.

Authors:  Ryang Hwa Lee; Ji Min Yu; Andrea M Foskett; Grant Peltier; John C Reneau; Nikolay Bazhanov; Joo Youn Oh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

7.  Methylation of the promoter A of estrogen receptor alpha gene in hBMSC and osteoblasts and its correlation with homocysteine.

Authors:  Haihong Lv; Xiaolan Ma; Tuanjie Che; Yirong Chen
Journal:  Mol Cell Biochem       Date:  2011-04-27       Impact factor: 3.396

8.  Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss.

Authors:  Russell T Turner; Urszula T Iwaniec; Juan E Andrade; Adam J Branscum; Steven L Neese; Dawn A Olson; Lindsay Wagner; Victor C Wang; Susan L Schantz; William G Helferich
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

9.  Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis.

Authors:  M Yamaguchi; T Vikulina; J L Arbiser; M N Weitzmann
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

10.  Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell.

Authors:  Najing Zhou; Yunli Yan; Wenling Li; Yanling Wang; Lifen Zheng; Shuo Han; Yongxin Yan; Yunzhi Li
Journal:  Int J Mol Sci       Date:  2009-07-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.